The pLVX-EGFP-C1 vector is a lentiviral expression vector, designed for stable expression of cloned sequences. With a size of 8786 bp, it is engineered to carry a high copy number, which ensures the effective multiplication of the viruses. The vector employs the CMV promoter, known for providing high-level constitutive expression of genes in many different mammalian cell types such as 293, CV-1, CHO and others.
An important aspect of this vector is that it is engineered to provide resistance to ampicillin, thus facilitating the efficient selection of cells that have been successfully transfected. A further integral feature of the pLVX-EGFP-C1 vector is the inclusion of a puromycin resistance gene. This serves as a selectable marker, allowing for the targeted elimination of untransfected cells once introduced into the host system. This ensures that only cells carrying the recombinant vector continue to grow in culture.
Case Study 1
Polycystic ovary syndrome(PCOS)is a common endocrine and metabolic disease.Guizhi Fuling Wan(GZFLW)is commonly used to treat various gynecological diseases.Similar to metformin,GZFLW can effectively improve insulin resistance in PCOS patients,promote mature follicle development and ovulation,and improve insulin sensitivity in insulin-resistant PCOS model rats by reshaping intestinal homeostasis.The study here explores the potential molecular mechanism by which the GZFLW inhibits autophagy in granulosa cells(GCs)in polycystic ovary syndrome(PCOS).GZFLW intervention reduced the expression of autophagy-related proteins PTEN,MMP-2 and Bax by up-regulating the expression of miR-29b-3p and down-regulating the expression of H19.GZFLW treatment significantly reduced the number of autophagosomes and autophagic polymers.However,inhibition of miR-29b-3p and overexpression of H19 induced a significant increase in the number of autophagosomes and autophagic polymers,thereby attenuating the inhibitory effect of GZFLW on autophagy.
In this study,wild-type or mutant H19-MT,PTEN-MT,Bax-MT,and MMP-2-MT luciferase reporter plasmids were constructed using pLVX-EGFP-C1(purchased from Creative Biogene)and pMIR-REPORTE plasmids.Cells were co-transfected with wild-type or mutant luciferase reporter vectors and miR-29b-3p mimic or mimic-NC for 48 h.The results showed that H19 is a direct target of miR-29b-3p,and co-transfection of miR-29b-3p analogues with H19-WT significantly inhibited luciferase activity.Compared with the control group,the expression of H19 in GCs in the PCOS model group was significantly increased,and the expression of miR-29b-3p was significantly decreased.In contrast,the expression of H19 was significantly down-regulated,while the expression of miR-29b-3p was up-regulated after GZFLW administration.
Figure 1.GZFLW downregulates H19 and upregulates miR-29b-3p.(Wu P,et al.,2023)
Case Study 2
GZFLW regulates H19/miR-29-3p to inhibit autophagy.
Paper
2023
Gynecological Endocrinology |
DOI
Background
This study explored whether Guizhi Fuling Wan (GZFLW) inhibits granulosa cell autophagy in polycystic ovary syndrome (PCOS) via the H19/miR-29b-3p pathway. PCOS model and control granulosa cells were treated with GZFLW-containing serum. qRT-PCR, luciferase assays, western blot, MDC staining, and mRFP-eGFP-LC3 imaging assessed H19, miR-29b-3p, PTEN, MMP-2, Bax, and autophagy. GZFLW downregulated H19, upregulated miR-29b-3p, reduced PTEN/MMP-2/Bax, and decreased autophagosomes. Inhibiting miR-29b-3p or overexpressing H19 reversed these effects, confirming that GZFLW suppresses PCOS granulosa cell autophagy through H19/miR-29b-3p.
Key Findings
GZFLW treatment significantly downregulated H19 and upregulated miR-29b-3p in PCOS granulosa cells (p<.01). Luciferase assays confirmed H19 as a direct target of miR-29b-3p and verified binding sites for miR-29b-3p in PTEN, MMP-2, and Bax. GZFLW reduced PTEN, MMP-2, and Bax protein levels in PCOS cells (p<.01). MDC staining and mRFP-eGFP-LC3 imaging showed that PCOS granulosa cells had increased autophagic vesicles, autophagosomes, and autophagic polymers, while GZFLW treatment markedly decreased these autophagy markers (p<.01). Inhibition of miR-29b-3p or overexpression of H19 reversed GZFLW's suppression of autophagy and attenuated its effects on PTEN, MMP-2, and Bax (p<.05 or p<.01). Thus, GZFLW inhibits excessive granulosa cell autophagy in PCOS via the H19/miR-29b-3p pathway, providing a potential therapeutic mechanism for PCOS.
Contribution
Creative Biogene supplied the pLVX-EGFP-C1 plasmid used in this study. This lentiviral vector likely facilitated H19 overexpression experiments, which were critical for showing that H19 reverses GZFLW-induced autophagy inhibition. Therefore, Creative Biogene provided an essential molecular tool for interrogating the H19/miR-29b-3p pathway, though the company did not participate in study design, data collection, or analysis.
The pLVX-EGFP-C1 vector is a very versatile tool used in various applications of molecular biology, cell biology, and biomedical research. Here are a few of its key applications:
Gene Expression Studies: The pLVX-EGFP-C1 vector is used for delivering and expressing genes of interest in target cells. Being a lentiviral vector, it allows stable long-term gene expression in both dividing and non-dividing cells.
Fluorescent Reporter System: The vector is equipped with an enhanced Green Fluorescent Protein (EGFP) reporter gene which enables researchers to easily track the transduction efficiency and expression of the gene of interest in target cells. Fluorescence microscopy, flow cytometry, and other fluorescence-based methods can be used for this purpose.
Functional Genomic Studies: This includes gene overexpression or downregulation studies, gene function explorations, and more.
Cell Line Generation: The pLVX-EGFP-C1 vector is often used to generate stably transfected cell lines. These cell lines can serve as models to study and understand the role of a particular gene in disease pathology, drug development, cell signaling, cellular interactions, etc.
In Vivo Studies: Because of its ability to infect non-dividing cells and persist in the host cells, the pLVX-EGFP-C1 vector has been used for in vivo gene delivery.
Drug Screening and Discovery: This vector can also be useful for creating cell lines expressing a drug target, hence, it can be used for drug screening and discovery.
Customer Q&As
What is pLVX-EGFP-C1?
A: pLVX-EGFP-C1 is a lentiviral expression vector that can be used for stable or transient expression of genes in mammalian cells. It has been modified to include the enhanced green fluorescent protein (EGFP) reporter gene, which allows for the easy detection of transfected cells.
What type of vector is pLVX-EGFP-C1?
A: pLVX-EGFP-C1 is a Viral Expression & Packaging Vector.
What are the possible applications of pLVX-EGFP-C1?
A: pLVX-EGFP-C1 can be used for a wide variety of cell biology research applications, such as gene function studies and production of stable cell lines.
Ask a Question
Customer Reviews
It works exceptionally well
I've used the pLVX-EGFP-C1 vector in several of my experiments and I must say, it works exceptionally well.
Effective tool
The pLVX-EGFP-C1 vector ticks all boxes for a reliable, effective tool in gene expression studies. The user-friendly design, combined with the powerful EGFP tag, makes it an important staple in our lab.
Write a Review